Media Center

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

What are we expecting in EGFR-mutant NSCLC in 2023?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Key data releases at the congress: An outlook of publication highlights and their potential implications for optimised treatment of patients with MS

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

MS management strategies relating to women of childbearing potential: Speaker debate

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

MS management strategies relating to women of childbearing potential: The argument for induction treatment strategies

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

MS management strategies relating to women of childbearing potential: The argument for escalation treatment strategies

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: Clinical scenario of the right patient selection

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Cognitive functions and fatigue during MS therapy: an update

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 MS patient monitoring in clinical practice – how the latest research results are applied

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of safety?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of clinical effectiveness?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Latest updates in MS: MSTCG position statement, ECTRIMS guidelines

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 2

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 1

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

How different patient factors affect a treatment switching decision: How can we handle complex scenarios in clinical practice?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

How different patient factors affect a treatment switching decision: What evidence do the guidelines provide?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Adapting to complicated patient characteristics when initiating treatment: How can we handle complex scenarios in clinical practice?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Adapting to complicated patient characteristics when initiating treatment: What evidence do the guidelines provide?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

The evolving role of nurse specialists in the management of patients with multiple myeloma

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Highlights from the 11th International Workshop on Waldenström’s Macroglobulinemia

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Managing cardiac comorbidities in patients with chronic lymphocytic leukemia: an in-depth educational update

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Navigating the patient journey in AL amyloidosis: a multidisciplinary approach

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 3: Axial PsA, Part 5: What is important to know for the patient in front of us?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Title TAPAS Episode 3: Axial PsA, Part 4: What’s on the horizon for treating AxPsA and AxSpA?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 3: Axial PsA, Part 3: The unmet needs and clinical challenges in the treatment of AxPsA and AxSpA

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 3: Axial PsA, Part 2: Similarities and differences between AxPsA and AxSpA

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 3: Axial PsA, Part 1: The diagnostic criteria for AxPsA and AxSpA

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in NHL: Optimising first-line treatment in MCL

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in CLL: How risk stratification can guide the choice of first-line treatment in patients with CLL

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in CLL: Continuous, time-limited, or MRD-guided therapy

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Pre-ASH on CLL - Challenges in CLL: How would the data from ASH 2022 impact your clinical practice?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

MRD - What will change in the next year?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

The role of the multidisciplinary team in the management of patients with AL amyloidosis

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

How do we ensure we choose the right treatment for the right patient?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Applications of testing modalities in NSCLC: An overview of investigational techniques

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Molecular biomarkers in CLL: guiding clinical decision making

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Manipulating the neurodegenerative component and avoiding progression by using S1P receptor modulators: What’s the latest evidence?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Clinical evidence of inflammation in neurodegeneration

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Basic science of inflammation in neurodegeneration

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Minimal residual disease (MRD): the big question mark in CLL

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Optimizing treatment selection and sequencing for patients with multiple myeloma: precision medicine approach

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Immunotherapy: evolution or revolution in the cure of multiple myeloma

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Where are we with MRD assessment in CLL management?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in CLL: What does the future hold - are we approaching cure in CLL?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in CLL: How do the data from EHA 2022 inform key management questions?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Is cure attainable in patients with multiple myeloma?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

How do you plan the patient journey at diagnosis for patients with multiple myeloma?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Bridging the gap between patient and clinician perspectives in myeloma care

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Practical considerations around CAR T-cell therapies for MM patients

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Bispecific antibodies: raising new horizons for relapsed/refractory multiple myeloma?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Expert insights and clinical implications for the management of patients with multiple myeloma

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in NHL: Future strategies and new treatment algorithms in MCL

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in NHL: Managing WM-associated complications: a case study based discussion

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Challenges in NHL: how does the data from EHA 2022 inform key management questions?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Managing cardiac comorbidities in patients with CLL

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

That’s a wrap! A review of bladder cancer news in 2022

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Transforming the landscape of multiple myeloma with CAR T-cell therapies

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Moving Fourth - Living with HIV has been redefined - November 2022

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Part 3: Panel discussion 2

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Part 1: Presentation

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Full video

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Part 2: Panel discussion

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Part 1: Presentation

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Full video

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Part 2: Panel discussion

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Part 1: Presentation

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Full video

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

2022 in review: Updates in EGFR-mutant NSCLC

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Should we focus on inflammation to stop neurodegeneration and prevent progression?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Zooming in on MS: Taking on the challenge of adapting treatment strategies to the needs of specific patient groups

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Zooming in on MS: Exploring treatment consensus and controversy surrounding complex patients

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Controversies in prostate cancer care: Real-world management of patients with mHSPC

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

A review of prostate cancer in 2022

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

An overview of activating EGFR mutations in NSCLC

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

An overview of gene fusions in NSCLC

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 6: What have we learned so far?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 5: What does this all mean for the clinic?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 4: My gut feeling about safety

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 3: Gutting the problem in psoriasis and PsA

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 2: Leaky, leaky organs

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

TAPAS Episode 2: The leaky gut, Part 1: The gut and you

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

NET - Medical Education - Vaccine Development - Meet Dr. Jenny Hendriks

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

ESMO 2022 - Experts views on prostate cancer new from September

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Developments in molecular testing for NSCLC: How is practice evolving?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Developments in molecular testing for NSCLC: A comprehensive approach

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

What do UC on the horizon: exploring the emerging management options

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Avant-garde treatment approaches in IBD management: targeting the IL-23 pathway

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Exploring the evolution of care in Crohn’s disease

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Expert views on bladder cancer news from September 2022

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Dr Guido van den Berk

Internist, Infectious Diseases Physician, Department of Internal Medicine, OLVG, City Hospital of Greater Amsterdam, The Netherlands

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Dr Giovanni Guaraldi (Chair)

Associate Professor of Infectious Disease and Head of the Modena HIV Metabolic Clinic (MHMC), Italy

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Dr Eugenio Teofilo

Department of Internal Medicine at Hospital Dos Capuchos, Lisboa, Portugal

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Dr Adrian Curran

Internist, Infectious Diseases Physician, Department of Infectious Diseases, Vall d’Hebron University Hospital, Barcelona, Spain

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Mario Cascio

Programme Chair for Quality of Life, European AIDS Treatment Group (EATG), Italy

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Dr Joop Arends

Internist, Infectious Diseases Physician, Founder HappiApp, Board member HappiApp Foundation and Director PatientApp

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

Manage cookie settings

Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come

What are we expecting in EGFR-mutant NSCLC in 2023?

Key data releases at the congress: An outlook of publication highlights and their potential implications for optimised treatment of patients with MS

MS management strategies relating to women of childbearing potential: Speaker debate

MS management strategies relating to women of childbearing potential: The argument for induction treatment strategies

MS management strategies relating to women of childbearing potential: The argument for escalation treatment strategies

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: Clinical scenario of the right patient selection

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Cognitive functions and fatigue during MS therapy: an update

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 MS patient monitoring in clinical practice – how the latest research results are applied

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of safety?

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of clinical effectiveness?

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Latest updates in MS: MSTCG position statement, ECTRIMS guidelines

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 2

Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 1

How different patient factors affect a treatment switching decision: How can we handle complex scenarios in clinical practice?

How different patient factors affect a treatment switching decision: What evidence do the guidelines provide?

Adapting to complicated patient characteristics when initiating treatment: How can we handle complex scenarios in clinical practice?

Adapting to complicated patient characteristics when initiating treatment: What evidence do the guidelines provide?

The evolving role of nurse specialists in the management of patients with multiple myeloma

Highlights from the 11th International Workshop on Waldenström’s Macroglobulinemia

Managing cardiac comorbidities in patients with chronic lymphocytic leukemia: an in-depth educational update

Navigating the patient journey in AL amyloidosis: a multidisciplinary approach

TAPAS Episode 3: Axial PsA, Part 5: What is important to know for the patient in front of us?

Title TAPAS Episode 3: Axial PsA, Part 4: What’s on the horizon for treating AxPsA and AxSpA?

TAPAS Episode 3: Axial PsA, Part 3: The unmet needs and clinical challenges in the treatment of AxPsA and AxSpA

TAPAS Episode 3: Axial PsA, Part 2: Similarities and differences between AxPsA and AxSpA

TAPAS Episode 3: Axial PsA, Part 1: The diagnostic criteria for AxPsA and AxSpA

Challenges in NHL: Optimising first-line treatment in MCL

Challenges in CLL: How risk stratification can guide the choice of first-line treatment in patients with CLL

Challenges in CLL: Continuous, time-limited, or MRD-guided therapy

Pre-ASH on CLL - Challenges in CLL: How would the data from ASH 2022 impact your clinical practice?

MRD - What will change in the next year?

What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?

The role of the multidisciplinary team in the management of patients with AL amyloidosis

How do we ensure we choose the right treatment for the right patient?

What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?

A focus on standard-risk patients with MM and the roadmap to cure

Expert views on prostate cancer news from February 2023

Epidemiology of lung cancer

Screening in lung cancer

Applications of testing modalities in NSCLC: Current and future practices

Fundamentals of pathology in NSCLC: An overview

Applications of testing modalities in NSCLC: An overview of investigational techniques

Molecular biomarkers in CLL: guiding clinical decision making

Manipulating the neurodegenerative component and avoiding progression by using S1P receptor modulators: What’s the latest evidence?

Clinical evidence of inflammation in neurodegeneration

Basic science of inflammation in neurodegeneration

Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma

Minimal residual disease (MRD): the big question mark in CLL

Optimizing treatment selection and sequencing for patients with multiple myeloma: precision medicine approach

Immunotherapy: evolution or revolution in the cure of multiple myeloma

Where are we with MRD assessment in CLL management?

Challenges in CLL: What does the future hold - are we approaching cure in CLL?

Challenges in CLL: How do the data from EHA 2022 inform key management questions?

Is cure attainable in patients with multiple myeloma?

How do you plan the patient journey at diagnosis for patients with multiple myeloma?

Bridging the gap between patient and clinician perspectives in myeloma care

Practical considerations around CAR T-cell therapies for MM patients

Bispecific antibodies: raising new horizons for relapsed/refractory multiple myeloma?

Expert insights and clinical implications for the management of patients with multiple myeloma

Challenges in NHL: Future strategies and new treatment algorithms in MCL

Challenges in NHL: Managing WM-associated complications: a case study based discussion

Challenges in NHL: how does the data from EHA 2022 inform key management questions?

Managing cardiac comorbidities in patients with CLL

That’s a wrap! A review of bladder cancer news in 2022

Transforming the landscape of multiple myeloma with CAR T-cell therapies

Moving Fourth - Living with HIV has been redefined - November 2022

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Part 3: Panel discussion 2

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Part 1: Presentation

PAPERS Episode 3: Drug survival of IL-17 and IL-23 inhibitors for the treatment of psoriasis – Full video

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Part 2: Panel discussion

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Part 1: Presentation

PAPERS Episode 2: Long-term safety of guselkumab in patients with psoriasis – Full video

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Part 2: Panel discussion

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Part 1: Presentation

PAPERS Episode 1: Axial PsA in the CorEvitas PsA and spondyloarthritis registry and the role of neutrophils in spondyloarthritis – Full video

2022 in review: Updates in EGFR-mutant NSCLC

Should we focus on inflammation to stop neurodegeneration and prevent progression?

Zooming in on MS: Taking on the challenge of adapting treatment strategies to the needs of specific patient groups

Zooming in on MS: Exploring treatment consensus and controversy surrounding complex patients